343 related articles for article (PubMed ID: 23828376)
1. Inhibitory effects of STAT3 decoy oligodeoxynucleotides on human epithelial ovarian cancer cell growth in vivo.
Zhang X; Liu P; Zhang B; Mao H; Shen L; Ma Y
Int J Mol Med; 2013 Sep; 32(3):623-8. PubMed ID: 23828376
[TBL] [Abstract][Full Text] [Related]
2. STAT3 Decoy Oligodeoxynucleotides-Loaded Solid Lipid Nanoparticles Induce Cell Death and Inhibit Invasion in Ovarian Cancer Cells.
Ma Y; Zhang X; Xu X; Shen L; Yao Y; Yang Z; Liu P
PLoS One; 2015; 10(4):e0124924. PubMed ID: 25923701
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice.
Zhang X; Zhang J; Wang L; Wei H; Tian Z
BMC Cancer; 2007 Aug; 7():149. PubMed ID: 17683579
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of decoy oligodeoxynucleotides targeted to NF-kappaB in vitro and in vivo.
Wang T; Li QH; Hao GP; Zhai J
Asian Pac J Cancer Prev; 2010; 11(1):193-200. PubMed ID: 20593956
[TBL] [Abstract][Full Text] [Related]
5. Blockage of STAT3 signaling pathway with a decoy oligodeoxynucleotide inhibits growth of human ovarian cancer cells.
Liu M; Wang F; Wen Z; Shi M; Zhang H
Cancer Invest; 2014 Jan; 32(1):8-12. PubMed ID: 24328557
[TBL] [Abstract][Full Text] [Related]
6. Role of STAT3 decoy oligodeoxynucleotides on cell invasion and chemosensitivity in human epithelial ovarian cancer cells.
Zhang X; Liu P; Zhang B; Wang A; Yang M
Cancer Genet Cytogenet; 2010 Feb; 197(1):46-53. PubMed ID: 20113836
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of STAT3 at Tyr705 regulates MMP-9 production in epithelial ovarian cancer.
Jia ZH; Jia Y; Guo FJ; Chen J; Zhang XW; Cui MH
PLoS One; 2017; 12(8):e0183622. PubMed ID: 28859117
[TBL] [Abstract][Full Text] [Related]
8. IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells.
Zhu X; Shen H; Yin X; Long L; Chen X; Feng F; Liu Y; Zhao P; Xu Y; Li M; Xu W; Li Y
Oncotarget; 2017 Jun; 8(24):39154-39166. PubMed ID: 28388577
[TBL] [Abstract][Full Text] [Related]
9. Euxanthone inhibits glycolysis and triggers mitochondria-mediated apoptosis by targeting hexokinase 2 in epithelial ovarian cancer.
Zou J; Wang Y; Liu M; Huang X; Zheng W; Gao Q; Wang H
Cell Biochem Funct; 2018 Aug; 36(6):303-311. PubMed ID: 29984416
[TBL] [Abstract][Full Text] [Related]
10. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
[TBL] [Abstract][Full Text] [Related]
11. Abrogation of constitutive Stat3 activity circumvents cisplatin resistant ovarian cancer.
Ji T; Gong D; Han Z; Wei X; Yan Y; Ye F; Ding W; Wang J; Xia X; Li F; Hu W; Lu Y; Wang S; Zhou J; Ma D; Gao Q
Cancer Lett; 2013 Dec; 341(2):231-9. PubMed ID: 23962558
[TBL] [Abstract][Full Text] [Related]
12. Application of decoy oligodeoxynucleotides strategy for inhibition of cell growth and reduction of metastatic properties in nonresistant and erlotinib-resistant SW480 cell line.
Asadi Z; Fathi M; Rismani E; Bigdelou Z; Johari B
Cell Biol Int; 2021 May; 45(5):1001-1014. PubMed ID: 33377576
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of STAT3 decoy oligodeoxynucleotides' synergistic effects on radiation and/or chemotherapy in metastatic breast cancer cell line.
Johari B; Rahmati M; Nasehi L; Mortazavi Y; Faghfoori MH; Rezaeejam H
Cell Biol Int; 2020 Dec; 44(12):2499-2511. PubMed ID: 32841450
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of matrix metalloproteinase 9 by small interfering RNA inhibits the tumor growth of ovarian epithelial carcinoma in vitro and in vivo.
Guo F; Tian J; Cui M; Fang M; Yang L
Mol Med Rep; 2015 Jul; 12(1):753-9. PubMed ID: 25738807
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
16. Inorganic kernel - Supported asymmetric hybrid vesicles for targeting delivery of STAT3-decoy oligonucleotides to overcome anti-HER2 therapeutic resistance of BT474R.
Shi K; Fang Y; Gao S; Yang D; Bi H; Xue J; Lu A; Li Y; Ke L; Lin X; Jin X; Li M
J Control Release; 2018 Jun; 279():53-68. PubMed ID: 29655990
[TBL] [Abstract][Full Text] [Related]
17. G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice.
Gekeler V; Gimmnich P; Hofmann HP; Grebe C; Römmele M; Leja A; Baudler M; Benimetskaya L; Gonser B; Pieles U; Maier T; Wagner T; Sanders K; Beck JF; Hanauer G; Stein CA
Oligonucleotides; 2006; 16(1):83-93. PubMed ID: 16584297
[TBL] [Abstract][Full Text] [Related]
18. Blockage of the STAT3 signaling pathway with a decoy oligonucleotide suppresses growth of human malignant glioma cells.
Gu J; Li G; Sun T; Su Y; Zhang X; Shen J; Tian Z; Zhang J
J Neurooncol; 2008 Aug; 89(1):9-17. PubMed ID: 18415045
[TBL] [Abstract][Full Text] [Related]
19. The inhibitory effect of doxycycline on cisplatin-sensitive and -resistant epithelial ovarian cancer.
Wu W; Yu LH; Ma B; Xu MJ
PLoS One; 2014; 9(3):e89841. PubMed ID: 24598933
[TBL] [Abstract][Full Text] [Related]
20. Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer.
Chaluvally-Raghavan P; Jeong KJ; Pradeep S; Silva AM; Yu S; Liu W; Moss T; Rodriguez-Aguayo C; Zhang D; Ram P; Liu J; Lu Y; Lopez-Berestein G; Calin GA; Sood AK; Mills GB
Cell Rep; 2016 May; 15(7):1493-1504. PubMed ID: 27160903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
